Koninklijke Philips (PHG) Cash from Financing Activities (2009 - 2026)

Koninklijke Philips (PHG) recorded quarterly Cash from Financing Activities of -$26.9 million in Q1 2026, up 92.82% quarter-over-quarter from -$374.8 million in Q4 2025, and up 46.67% on a YoY basis from -$18.4 million in Q1 2025.

Koninklijke Philips (PHG) Cash from Financing Activities (2009 - 2026) Analysis & Trends

Koninklijke Philips' Cash from Financing Activities history runs 18 years deep, the most recent figure standing at -$26.9 million for Q1 2026.

  • In Q1 2026, Cash from Financing Activities rose 46.67% year-over-year to -$26.9 million; the TTM figure through Mar 2026 stood at $717.8 million (up 258.02% YoY), while the FY2025 annual figure was $124.6 million, up 123.5% from the prior year.
  • Cash from Financing Activities was -$26.9 million for Q1 2026 at Koninklijke Philips, up from -$374.8 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $618.0 million in Q2 2025 to a low of -$912.4 million in Q4 2023.
  • Historically, Cash from Financing Activities has averaged -$49.4 million across 5 years, with a median of -$92.1 million in 2024.
  • The sharpest annual moves came in 2023 and 2024: Cash from Financing Activities slumped 149.12% in 2023, then surged 378.44% in 2024.
  • A 5-year view of Cash from Financing Activities shows it stood at $372.4 million in 2022, then tumbled by 345.0% to -$912.4 million in 2023, then surged by 36.87% to -$576.0 million in 2024, then surged by 34.92% to -$374.8 million in 2025, then soared by 92.82% to -$26.9 million in 2026.
  • The last three Cash from Financing Activities figures came in at -$26.9 million (Q1 2026), -$374.8 million (Q4 2025), and $501.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 17.31 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn -1.51 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn -2.09 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn -260.00 Mn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -451.20 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -26.93 Mn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -25.00 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 21.00 Mn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -97.90 Mn
10 Zimmer Biomet Holdings 17.18 Bn 16.77 Bn 1.51 Bn -369.20 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -26.93 Mn
Mar 31, 2026 -26.93 Mn
Dec 31, 2025 -374.82 Mn
Dec 31, 2025 -374.82 Mn
Sep 30, 2025 501.52 Mn
Sep 30, 2025 501.52 Mn
Jun 30, 2025 618.05 Mn
Jun 30, 2025 618.05 Mn
Mar 31, 2025 -50.49 Mn
Mar 31, 2025 -50.49 Mn
Dec 31, 2024 -575.97 Mn
Dec 31, 2024 -575.97 Mn
Sep 30, 2024 -337.15 Mn
Sep 30, 2024 -337.15 Mn
Jun 30, 2024 509.37 Mn
Jun 30, 2024 509.37 Mn
Mar 31, 2024 -133.62 Mn
Mar 31, 2024 -133.62 Mn
Dec 31, 2023 -912.40 Mn
Dec 31, 2023 -912.40 Mn